Royal Bank of Canada reiterated their underperform rating on shares of Reckitt Benckiser Group (LON:RB) in a research note issued to investors on Wednesday, April 10th, ThisIsMoney.Co.Uk reports. They currently have a GBX 5,300 ($69.25) target price on the stock.
RB has been the subject of a number of other reports. JPMorgan Chase & Co. set a GBX 9,000 ($117.60) target price on shares of Reckitt Benckiser Group and gave the stock a buy rating in a report on Wednesday, January 16th. Jefferies Financial Group restated an underperform rating and set a GBX 5,400 ($70.56) price objective (up previously from GBX 5,000 ($65.33)) on shares of Reckitt Benckiser Group in a report on Friday, April 5th. Bryan, Garnier & Co started coverage on shares of Reckitt Benckiser Group in a report on Friday, April 5th. They set a neutral rating and a GBX 6,800 ($88.85) price objective on the stock. UBS Group restated a neutral rating and set a GBX 6,400 ($83.63) price objective on shares of Reckitt Benckiser Group in a report on Monday, February 18th. Finally, Liberum Capital restated a buy rating and set a GBX 7,300 ($95.39) price objective on shares of Reckitt Benckiser Group in a report on Monday, February 4th. Three investment analysts have rated the stock with a sell rating, five have issued a hold rating and eleven have issued a buy rating to the stock. Reckitt Benckiser Group presently has a consensus rating of Hold and an average price target of GBX 7,090 ($92.64).
Shares of RB traded down GBX 22 ($0.29) during trading hours on Wednesday, reaching GBX 6,064 ($79.24). 1,357,280 shares of the company traded hands, compared to its average volume of 1,720,000. The firm has a market capitalization of $42.92 billion and a P/E ratio of 19.90. Reckitt Benckiser Group has a 12-month low of GBX 5,411 ($70.70) and a 12-month high of GBX 7,174 ($93.74). The company has a current ratio of 0.65, a quick ratio of 0.47 and a debt-to-equity ratio of 80.49.
In other news, insider Elane Stock bought 1,860 shares of the stock in a transaction that occurred on Tuesday, February 19th. The stock was bought at an average cost of GBX 6,233 ($81.45) per share, for a total transaction of £115,933.80 ($151,488.04). Also, insider Andrew R. J. Bonfield bought 80 shares of the stock in a transaction that occurred on Thursday, February 28th. The shares were purchased at an average price of GBX 5,760 ($75.26) per share, with a total value of £4,608 ($6,021.17).
About Reckitt Benckiser Group
Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.
Further Reading: What is the Ex-Dividend Date in Investing?
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.